AI-assisted, human-published
07/08/2025 /Funding Events
Centivax Secures $45 Million for Universal Flu Vaccine Development
Biotech company Centivax closes oversubscribed Series A financing led by Steve Jurvetson of Future Ventures to support the development of a universal flu vaccine.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com